Latest Cetuximab Stories
SYDNEY, January 29, 2015 /PRNewswire/ -- Combined data from more than 1,000 patients being collected to assess overall survival (OS) benefit of adding first-line
Novel Diagnostic Helping Answer U.S. President's Call for Action on Precision Medicine Initiative JERUSALEM, Jan.
- Array to receive global rights from Novartis to innovative BRAF inhibitor - BOULDER, Colo., Jan. 23, 2015 /PRNewswire/ -- Array BioPharma Inc.
DALLAS, January 23, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced
Prospective clinical studies to evaluate Trovagene's Precision Cancer Monitoring platform to determine the emergence of resistance mutations using circulating tumor DNA SAN DIEGO,
Trovagene's proprietary KRAS assay enables physicians to determine mutational status, monitor treatment response, and use genomics to aid in predicting patient prognosis SAN DIEGO,
Exploratory Analysis of Phase 2 Trial Shows Earlier and Sustained Responses in Patients Treated With Vectibix Versus Bevacizumab THOUSAND OAKS, Calif., Jan.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.